Literature DB >> 23336052

5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10.

Maud Cochet1, Romain Donneger, Elisabeth Cassier, Florence Gaven, Stefan F Lichtenthaler, Philippe Marin, Joël Bockaert, Aline Dumuis, Sylvie Claeysen.   

Abstract

In addition to the amyloidogenic pathway, amyloid precursor protein (APP) can be cleaved by α-secretases, producing soluble and neuroprotective APP alpha (sAPPα) (nonamyloidogenic pathway) and thus preventing the generation of pathogenic amyloid-β. However, the mechanisms regulating APP cleavage by α-secretases remain poorly understood. Here, we showed that expression of serotonin type 4 receptors (5-HT(4)Rs) constitutively (without agonist stimulation) induced APP cleavage by the α-secretase ADAM10 and the release of neuroprotective sAPPα in HEK-293 cells and cortical neurons. This effect was independent of cAMP production. Interestingly, we demonstrated that 5-HT(4) receptors physically interacted with the mature form of ADAM10. Stimulation of 5-HT(4) receptors by an agonist further increased sAPPα secretion, and this effect was mediated by cAMP/Epac signaling. These findings describe a new mechanism whereby a GPCR constitutively stimulates the cleavage of APP by α-secretase and promotes the nonamyloidogenic pathway of APP processing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23336052      PMCID: PMC3547471          DOI: 10.1021/cn300095t

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  46 in total

1.  Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice.

Authors:  M Cachard-Chastel; S Devers; S Sicsic; M Langlois; F Lezoualc'h; A M Gardier; C Belzung
Journal:  Behav Brain Res       Date:  2007-10-18       Impact factor: 3.332

Review 2.  5-HT(4) receptors: history, molecular pharmacology and brain functions.

Authors:  Joël Bockaert; Sylvie Claeysen; Valérie Compan; Aline Dumuis
Journal:  Neuropharmacology       Date:  2008-05-23       Impact factor: 5.250

3.  Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.

Authors:  Frank Tippmann; Jana Hundt; Anja Schneider; Kristina Endres; Falk Fahrenholz
Journal:  FASEB J       Date:  2009-01-14       Impact factor: 5.191

Review 4.  G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease.

Authors:  Amantha Thathiah; Bart De Strooper
Journal:  Sci Signal       Date:  2009-10-20       Impact factor: 8.192

5.  Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain.

Authors:  M Marcinkiewicz; N G Seidah
Journal:  J Neurochem       Date:  2000-11       Impact factor: 5.372

6.  Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.

Authors:  Minji Kim; Jaehong Suh; Donna Romano; Mimy H Truong; Kristina Mullin; Basavaraj Hooli; David Norton; Giuseppina Tesco; Kathy Elliott; Steven L Wagner; Robert D Moir; K David Becker; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2009-07-15       Impact factor: 6.150

7.  Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation.

Authors:  Jennifer L Warner-Schmidt; Marc Flajolet; Abigail Maller; Emily Y Chen; Hongshi Qi; Per Svenningsson; Paul Greengard
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

8.  Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats.

Authors:  Carrie K Jones; Ashley E Brady; Albert A Davis; Zixiu Xiang; Michael Bubser; Mohammed Noor Tantawy; Alexander S Kane; Thomas M Bridges; J Phillip Kennedy; Stefania R Bradley; Todd E Peterson; M Sib Ansari; Ronald M Baldwin; Robert M Kessler; Ariel Y Deutch; James J Lah; Allan I Levey; Craig W Lindsley; P Jeffrey Conn
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

9.  A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease.

Authors:  Shirley W Tsang; Janet Keene; Tony Hope; Ian Spence; Paul T Francis; Peter T-H Wong; Christopher P Chen; Mitchell K Lai
Journal:  J Neurol Sci       Date:  2009-10-08       Impact factor: 3.181

10.  Conformational toggle switches implicated in basal constitutive and agonist-induced activated states of 5-hydroxytryptamine-4 receptors.

Authors:  Lucie P Pellissier; Jessica Sallander; Mercedes Campillo; Florence Gaven; Emilie Queffeulou; Marion Pillot; Aline Dumuis; Sylvie Claeysen; Joël Bockaert; Leonardo Pardo
Journal:  Mol Pharmacol       Date:  2009-01-23       Impact factor: 4.436

View more
  26 in total

1.  Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.

Authors:  Cédric Lecoutey; Damien Hedou; Thomas Freret; Patrizia Giannoni; Florence Gaven; Marc Since; Valentine Bouet; Céline Ballandonne; Sophie Corvaisier; Aurélie Malzert Fréon; Serge Mignani; Thierry Cresteil; Michel Boulouard; Sylvie Claeysen; Christophe Rochais; Patrick Dallemagne
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

Review 2.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

Review 3.  An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels.

Authors:  Xiaoling Zhou; Yifei Li; Xiaozhe Shi; Chun Ma
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  First-in-Human Studies to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Novel 5-HT4 Partial Agonist, SUVN-D4010, in Healthy Adult and Elderly Subjects.

Authors:  Ramakrishna Nirogi; Gopinadh Bhyrapuneni; Nageswara Rao Muddana; Vinod Kumar Goyal; Santosh Kumar Pandey; Abdul Rasheed Mohammed; Jyothsna Ravula; Satish Jetta; Veera Raghava Chowdary Palacharla
Journal:  Clin Drug Investig       Date:  2021-03-31       Impact factor: 2.859

Review 5.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

6.  Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer's Disease.

Authors:  Andréa V Maglione; Bruna P P do Nascimento; Miriam O Ribeiro; Talytha J L de Souza; Renata E C da Silva; Monica A Sato; Carlos A A Penatti; Luiz R G Britto; Janaina S de Souza; Rui M B Maciel; Rodrigo Rodrigues da Conceição; Roberto Laureano-Melo; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2022-08-11       Impact factor: 3.655

7.  The effect of citalopram treatment on amyloid-β precursor protein processing and oxidative stress in human hNSC-derived neurons.

Authors:  R J Elsworthy; J A Crowe; M C King; C Dunleavy; E Fisher; A Ludlam; H R Parri; E J Hill; S Aldred
Journal:  Transl Psychiatry       Date:  2022-07-18       Impact factor: 7.989

Review 8.  Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.

Authors:  Tapan Behl; Dapinder Kaur; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Gokhan Zengin; Felicia Liana Andronie-Cioara; Mirela Marioara Toma; Simona Bungau; Adrian Gheorghe Bumbu
Journal:  Molecules       Date:  2021-06-18       Impact factor: 4.411

9.  Developing BACE-1 inhibitors for FXS.

Authors:  Cara J Westmark; Elizabeth M Berry-Kravis; Chrysanthy Ikonomidou; Jerry C P Yin; Luigi Puglielli
Journal:  Front Cell Neurosci       Date:  2013-05-28       Impact factor: 5.505

10.  Serotonin enhances depolarizing spontaneous fluctuations, excitability, and ongoing activity in isolated rat DRG neurons via 5-HT4 receptors and cAMP-dependent mechanisms.

Authors:  Elia R Lopez; Anibal Garza Carbajal; Jin Bin Tian; Alexis Bavencoffe; Michael X Zhu; Carmen W Dessauer; Edgar T Walters
Journal:  Neuropharmacology       Date:  2020-11-18       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.